Clinical Trials Browser

Breast Carcinoma In Situ × Metformin × 90 days × Clear all

NCT01905046 2026-04-28

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Phase 3 Active not recruiting

86 enrolled 10 charts

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating